scispace - formally typeset
Open AccessJournal ArticleDOI

Global cancer statistics, 2012

Reads0
Chats0
TLDR
A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.
Abstract
Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Over the years, the burden has shifted to less developed countries, which currently account for about 57% of cases and 65% of cancer deaths worldwide. Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and has surpassed breast cancer as the leading cause of cancer death among females in more developed countries; breast cancer remains the leading cause of cancer death among females in less developed countries. Other leading causes of cancer death in more developed countries include colorectal cancer among males and females and prostate cancer among males. In less developed countries, liver and stomach cancer among males and cervical cancer among females are also leading causes of cancer death. Although incidence rates for all cancers combined are nearly twice as high in more developed than in less developed countries in both males and females, mortality rates are only 8% to 15% higher in more developed countries. This disparity reflects regional differences in the mix of cancers, which is affected by risk factors and detection practices, and/or the availability of treatment. Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 Kip1 axis

TL;DR: It is demonstrated that circYAP1 functions as a tumor suppressor in GC cells by targeting the miR-367-5p/p27 Kip1 axis and may provide a prognostic indicator of survival in GC patients.
Journal ArticleDOI

MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis

TL;DR: MiR-218 acts as a tumor suppressor in lung cancer via IL-6/STAT3 signaling pathway regulation and negatively regulated IL- 6 receptor and JAK3 gene expression by directly targeting the 3′-UTR of their mRNAs.
Journal ArticleDOI

Molecular pathogenesis of sporadic colorectal cancers

TL;DR: This review describes the genetic pathways of sporadic CRCs and their clinicopathologic features, and summarizes the present knowledge of this research field and discusses its prospects.
Journal ArticleDOI

LncRNA UCA1 in anti-cancer drug resistance.

TL;DR: The potential of lncRNA UCA1 as a diagnostic and prognostic biomarker, and a therapeutic target in malignant tumors, is highlighted and its potential in future clinical applications is discussed.
Journal ArticleDOI

The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus

TL;DR: For those resectable tumors, the better choice for treatment of HCC with PVTT should be hepatectomy and removal of PVTT, and the multidisciplinary treatments may further improve the quality of life and prolong the survival period for the HCC patients associated with PV TT.
References
More filters
Journal ArticleDOI

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

TL;DR: The GLOBOCAN series of the International Agency for Research on Cancer (IARC) as mentioned in this paper provides estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012.
Journal ArticleDOI

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans

TL;DR: This timely monograph is a distillation of knowledge of hepatitis B, C and D, based on a review of 1000 studies by a small group of scientists, and it is concluded that hepatitis D virus cannot be classified as a human carcinogen.
Book

Cancer Incidence in Five Continents

TL;DR: The aim of this study was to establish a database of histological groups and to provide a level of consistency and quality of data that could be applied in the design of future registries.
Journal ArticleDOI

Reduced lung-cancer mortality with low-dose computed tomographic screening.

TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.
Related Papers (5)
Trending Questions (3)
What is the average cancer death rate around the world?

The average cancer death rate worldwide is 8% to 15% higher in more developed countries compared to less developed countries, reflecting differences in cancer profiles and treatment availability.

Cancer statistics in the world

In 2012, there were approximately 14.1 million new cancer cases and 8.2 million deaths worldwide, with a shift towards less developed countries in terms of cancer burden.

Which are the current statistics for cancer worldwide?

The current statistics for cancer worldwide in 2012 were approximately 14.1 million new cases and 8.2 million deaths. Less developed countries accounted for 57% of cases and 65% of cancer deaths.